Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ferric carboxymaltose improves QOL in CHF patients

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Ferric carboxymaltose improves QOL in CHF patients. Pharmacoecon. Outcomes News 648, 9 (2012). https://doi.org/10.2165/00151234-201206480-00028

    Download citation

    Keywords

    • Placebo
    • Chronic Heart Failure
    • Iron Deficiency
    • Outcome News
    • Chronic Heart Failure Patient